iTeos Therapeutics
Yvonne joined iTeos in 2020 as Vice-President of Research & Development. With more than 20 years of international experience in oncology drug discovery and development, she has taken lead candidates from early stage research into clinical trials. Immediately prior to iTeos, she served as CSO and board member in Complix, a company developing novel biologics. She has also lead R&D activities in UK based biotech companies including Immunocore and Biovex.
Yvonne holds a PhD from the University of Wales, College of Medicine.
This person is not in any offices
iTeos Therapeutics
1 followers
Dedicated to extending and improving the lives of cancer patients by designing and developing next generation #immunotherapy treatments